Patty Eisenhaur
Investor Relations Contact bij MOMENTA PHARMACEUTICALS, INC.
Profiel
Patty Eisenhaur is currently working as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Senior Strategist at EVC Group, Inc. Previously, she worked as the Head-Investor Relations at Curia Global, Inc. from 2014 to 2018.
Actieve functies van Patty Eisenhaur
Bedrijven | Functie | Begin |
---|---|---|
MOMENTA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
EVC Group, Inc. | Corporate Officer/Principal | - |
Eerdere bekende functies van Patty Eisenhaur
Bedrijven | Functie | Einde |
---|---|---|
ALBANY MOLECULAR RESEARCH, INC. | Investor Relations Contact | 01-06-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Curia Global, Inc.
Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
EVC Group, Inc. |